These data, in parallel with the known chaperone function of GRP78, further support the therapeutic targeting of chaperones in the treatment of metabolic disorders and identify GRP78 as a cellular modulator of MC4R in the control of energy homeostasis. The gene discussed is HSPA5; the disease is Other metabolic disease.